Skip to main content
Top
Published in: Osteoporosis International 11/2020

Open Access 01-11-2020 | Osteoporosis | Original Article

Determinants of imminent fracture risk in postmenopausal women with osteoporosis

Authors: R. L. Barron, G. Oster, A. Grauer, D. B. Crittenden, D. Weycker

Published in: Osteoporosis International | Issue 11/2020

Login to get access

Abstract

Summary

In elderly women with osteoporosis, prior fracture, low BMD, impaired physical functioning, poorer general health, and recent falls were all direct predictors of imminent (in next year) fracture risk. Prior fracture, older age, worse health, impaired cognitive functioning, and recent falls indirectly increased imminent risk by reducing physical functioning/general health.

Introduction

This study was designed to examine determinants of imminent risk of osteoporotic fracture (i.e., next 1–2 years) in postmenopausal women.

Methods

This retrospective cohort study used data from Caucasian women age 65 or older with osteoporosis who participated in the observational Study of Osteoporotic Fractures (SOF). We examined potential direct and indirect predictors of hip and nonvertebral fractures in 1-year follow-up intervals including anthropometric measures, bone mineral density (T-score), fracture since age 50, physical function, cognition, medical conditions, recent (past year) falls, and lifestyle factors. Clinically related variables were grouped into constructs via factor analysis. These constructs and selected individual variables were incorporated into a theoretical structural equation model to evaluate factors that influence imminent risk.

Results

Among 2261 patients, 19.4% had a nonvertebral fracture and 5.5% had a hip fracture within 1 year of a study visit between 1992 and 2008. Prior fracture, lower T-scores, lower physical functioning, and recent falls all directly increased 1-year risk of nonvertebral fracture. For both nonvertebral and hip fractures, prior fracture and recent falls influenced risk indirectly through general health, while cognition influenced risk via physical functioning. Age influenced both physical functioning and general health.

Conclusions

Several established risk factors for 10-year fracture risk also played a role in predicting imminent risk of fracture (e.g., T-scores, prior fracture), as did falls, cognition, physical functioning, and general health. Fracture risk assessments should also consider falls and fall risk factors as well as established bone-related risk factors in assessing imminent fracture risk.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bliuc D, Nguyen ND, Nguyen TV, Eisman JA, Center JR (2013) Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and men. J Bone Miner Res 28:2317–2324CrossRef Bliuc D, Nguyen ND, Nguyen TV, Eisman JA, Center JR (2013) Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and men. J Bone Miner Res 28:2317–2324CrossRef
2.
go back to reference Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22:465–475CrossRef Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22:465–475CrossRef
3.
go back to reference Pike CT, Birnbaum HG, Schiller M, Swallow E, Burge RT, Edgell ET (2011) Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US. Osteoporos Int 22:2611–2621CrossRef Pike CT, Birnbaum HG, Schiller M, Swallow E, Burge RT, Edgell ET (2011) Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US. Osteoporos Int 22:2611–2621CrossRef
4.
go back to reference Hall SE, Williams JA, Senior JA, Goldswain PR, Criddle RA (2000) Hip fracture outcomes: quality of life and functional status in older adults living in the community. Aust N Z J Med 30:327–332CrossRef Hall SE, Williams JA, Senior JA, Goldswain PR, Criddle RA (2000) Hip fracture outcomes: quality of life and functional status in older adults living in the community. Aust N Z J Med 30:327–332CrossRef
5.
go back to reference Kanis JA, Borgström F, Compston J, Dreinhöfer K, Nolte E, Jonsson L, Lems WF, McCloskey EV, Rizzoli R, Stenmark J (2013) SCOPE: a scorecard for osteoporosis in Europe. Arch Osteoporos 8:144CrossRef Kanis JA, Borgström F, Compston J, Dreinhöfer K, Nolte E, Jonsson L, Lems WF, McCloskey EV, Rizzoli R, Stenmark J (2013) SCOPE: a scorecard for osteoporosis in Europe. Arch Osteoporos 8:144CrossRef
6.
go back to reference Tajeu GS, Delzell E, Smith W, Arora T, Curtis JR, Saag KG, Morrisey MA, Yun H, Kilgore ML (2014) Death, debility, and destitution following hip fracture. J Gerontol A Biol Sci Med Sci 69:346–353CrossRef Tajeu GS, Delzell E, Smith W, Arora T, Curtis JR, Saag KG, Morrisey MA, Yun H, Kilgore ML (2014) Death, debility, and destitution following hip fracture. J Gerontol A Biol Sci Med Sci 69:346–353CrossRef
7.
go back to reference Yusuf AA, Matlon TJ, Grauer A, Barron R, Chandler D, Peng Y (2016) Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries. Arch Osteoporos 11:31CrossRef Yusuf AA, Matlon TJ, Grauer A, Barron R, Chandler D, Peng Y (2016) Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries. Arch Osteoporos 11:31CrossRef
8.
go back to reference Yang X, Sajjan S, Modi A (2016) High rate of non-treatment among osteoporotic women enrolled in a US Medicare plan. Curr Med Res Opin 32:1849–1856CrossRef Yang X, Sajjan S, Modi A (2016) High rate of non-treatment among osteoporotic women enrolled in a US Medicare plan. Curr Med Res Opin 32:1849–1856CrossRef
10.
go back to reference Johnell O, Kanis JA, Odén A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jönsson B (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15:175–179CrossRef Johnell O, Kanis JA, Odén A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jönsson B (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15:175–179CrossRef
11.
go back to reference Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382CrossRef Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382CrossRef
12.
go back to reference Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397CrossRef Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397CrossRef
13.
go back to reference Lewiecki EM, Baron R, Bilezikian JP, Gagel RE, Leonard MB, Leslie WD, McClung MR, Miller PD (2016) Proceedings of the 2015 Santa Fe bone symposium: clinical applications of scientific advances in osteoporosis and metabolic bone disease. J Clin Densitom 19:102–116CrossRef Lewiecki EM, Baron R, Bilezikian JP, Gagel RE, Leonard MB, Leslie WD, McClung MR, Miller PD (2016) Proceedings of the 2015 Santa Fe bone symposium: clinical applications of scientific advances in osteoporosis and metabolic bone disease. J Clin Densitom 19:102–116CrossRef
14.
go back to reference Balasubramanian A, Wade SW, Adler RA, Lin CJF, Maricic M, O'Malley CD, Saag K, Curtis JR (2016) Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis. Osteoporos Int 27:3239–3249CrossRef Balasubramanian A, Wade SW, Adler RA, Lin CJF, Maricic M, O'Malley CD, Saag K, Curtis JR (2016) Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis. Osteoporos Int 27:3239–3249CrossRef
15.
go back to reference van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39:1383–1389CrossRef van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39:1383–1389CrossRef
16.
go back to reference van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993–1000CrossRef van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993–1000CrossRef
17.
go back to reference van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224–3229CrossRef van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224–3229CrossRef
18.
go back to reference Bonafede M, Shi N, Barron R, Li X, Crittenden DB, Chandler D (2016) Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data. Arch Osteoporos 11:26CrossRef Bonafede M, Shi N, Barron R, Li X, Crittenden DB, Chandler D (2016) Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data. Arch Osteoporos 11:26CrossRef
19.
go back to reference Muthén LK, Muthén BO (2012) Mplus user’s guide. Muthén & Muthén, Los Angeles Muthén LK, Muthén BO (2012) Mplus user’s guide. Muthén & Muthén, Los Angeles
20.
go back to reference Browne MW (2001) An overview of analytic rotations in exploratory factor analysis. Multivar Behav Res 36:111–150CrossRef Browne MW (2001) An overview of analytic rotations in exploratory factor analysis. Multivar Behav Res 36:111–150CrossRef
21.
go back to reference Browne MW, Cudeck R (1993) Alternative ways of assessing model fit. In: Bollen KA, Long JS (eds) Testing structural equation models. Sage, Newbury Park Browne MW, Cudeck R (1993) Alternative ways of assessing model fit. In: Bollen KA, Long JS (eds) Testing structural equation models. Sage, Newbury Park
22.
go back to reference Hu L, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model 6:1–55CrossRef Hu L, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model 6:1–55CrossRef
23.
go back to reference Adams A, Johnson E, Zhou H, Platt R, Wenkert D, Jabosen S, Balasubramanian A (2016) Prediction of two-year risk of fracture among older US women. J Bone Miner Res 31 Adams A, Johnson E, Zhou H, Platt R, Wenkert D, Jabosen S, Balasubramanian A (2016) Prediction of two-year risk of fracture among older US women. J Bone Miner Res 31
24.
go back to reference Balasubramanian A, Zhang J, Chen L, Wenkert D, Daigle SG, Grauer A, Curtis JR (2016) High risk of second fracture within 1, 2, 5 years after prior fracture among women 65 years or older. J Bone Miner Res 31 Balasubramanian A, Zhang J, Chen L, Wenkert D, Daigle SG, Grauer A, Curtis JR (2016) High risk of second fracture within 1, 2, 5 years after prior fracture among women 65 years or older. J Bone Miner Res 31
25.
go back to reference Hannan M, Weycker D, McLean R, Sahni S, Travison T, Bornheimer R, Dufour A, Barron R, Kiel D (2016) Predictors of imminent risk of non-vertebral fracture in older women: the Framingham osteoporosis study. J Bone Miner Res 31 Hannan M, Weycker D, McLean R, Sahni S, Travison T, Bornheimer R, Dufour A, Barron R, Kiel D (2016) Predictors of imminent risk of non-vertebral fracture in older women: the Framingham osteoporosis study. J Bone Miner Res 31
26.
go back to reference Yusuf A, Hu Y, Chandler D, Crittenden DB, Barron R (2016) Characteristics of patients at high one-year fracture risk. J Bone Miner Res 31 Yusuf A, Hu Y, Chandler D, Crittenden DB, Barron R (2016) Characteristics of patients at high one-year fracture risk. J Bone Miner Res 31
27.
go back to reference Weycker D, Barron R, Edelsberg J, Kartashov A, Crittenden DB, Grauer A (2015) Predictors of imminent fracture risk in women aged ≥65 years with osteoporosis. J Bone Miner Res 28 Weycker D, Barron R, Edelsberg J, Kartashov A, Crittenden DB, Grauer A (2015) Predictors of imminent fracture risk in women aged ≥65 years with osteoporosis. J Bone Miner Res 28
28.
go back to reference Gehlbach S, Saag KG, Adachi JD et al (2012) Previous fractures at multiple sites increase the risk for subsequent fractures: the global longitudinal study of osteoporosis in women. J Bone Miner Res 27:645–653CrossRef Gehlbach S, Saag KG, Adachi JD et al (2012) Previous fractures at multiple sites increase the risk for subsequent fractures: the global longitudinal study of osteoporosis in women. J Bone Miner Res 27:645–653CrossRef
29.
go back to reference McCloskey EV, Harvey NC, Johansson H, Kanis JA (2016) FRAX updates 2016. Curr Opin Rheumatol 28:433–441CrossRef McCloskey EV, Harvey NC, Johansson H, Kanis JA (2016) FRAX updates 2016. Curr Opin Rheumatol 28:433–441CrossRef
30.
go back to reference Dargent-Molina P, Favier F, Grandjean H, Baudoin C, Schott AM, Hausherr E, Meunier PJ, Bréart G (1996) Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet 348:145–149CrossRef Dargent-Molina P, Favier F, Grandjean H, Baudoin C, Schott AM, Hausherr E, Meunier PJ, Bréart G (1996) Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet 348:145–149CrossRef
31.
go back to reference Gärdsell P, Johnell O, Nilsson BE, Nilsson JA (1989) The predictive value of fracture, disease, and falling tendency for fragility fractures in women. Calcif Tissue Int 45:327–330CrossRef Gärdsell P, Johnell O, Nilsson BE, Nilsson JA (1989) The predictive value of fracture, disease, and falling tendency for fragility fractures in women. Calcif Tissue Int 45:327–330CrossRef
32.
go back to reference Harvey NC, Johansson H, Odén A et al (2016) FRAX predicts incident falls in elderly men: findings from MrOs Sweden. Osteoporos Int 27:267–274CrossRef Harvey NC, Johansson H, Odén A et al (2016) FRAX predicts incident falls in elderly men: findings from MrOs Sweden. Osteoporos Int 27:267–274CrossRef
33.
go back to reference Masud T, Binkley N, Boonen S, Hannan MT, Members FPDC (2011) Official positions for FRAX® clinical regarding falls and frailty: can falls and frailty be used in FRAX®? From joint official positions development conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. J Clin Densitom 14:194–204CrossRef Masud T, Binkley N, Boonen S, Hannan MT, Members FPDC (2011) Official positions for FRAX® clinical regarding falls and frailty: can falls and frailty be used in FRAX®? From joint official positions development conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. J Clin Densitom 14:194–204CrossRef
34.
go back to reference Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, Bagur A, Malouf-Sierra J, Lakatos P, Fahrleitner-Pammer A, Lespessailles E, Minisola S, Body JJ, Geusens P, Möricke R, López-Romero P (2018) Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 391:230–240CrossRef Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, Bagur A, Malouf-Sierra J, Lakatos P, Fahrleitner-Pammer A, Lespessailles E, Minisola S, Body JJ, Geusens P, Möricke R, López-Romero P (2018) Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 391:230–240CrossRef
35.
go back to reference Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377:1417–1427CrossRef Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377:1417–1427CrossRef
36.
go back to reference Roux C, Briot K (2017) Imminent fracture risk. Osteoporos Int 28:1765–1769CrossRef Roux C, Briot K (2017) Imminent fracture risk. Osteoporos Int 28:1765–1769CrossRef
37.
go back to reference Pinedo-Villanueva R, Charokopou M, Toth E, Donnelly K, Cooper C, Prieto-Alhambra D, Libanati C, Javaid MK (2019) Imminent fracture risk assessments in the UK FLS setting: implications and challenges. Arch Osteoporos 14:12CrossRef Pinedo-Villanueva R, Charokopou M, Toth E, Donnelly K, Cooper C, Prieto-Alhambra D, Libanati C, Javaid MK (2019) Imminent fracture risk assessments in the UK FLS setting: implications and challenges. Arch Osteoporos 14:12CrossRef
38.
go back to reference Looker AC, Borrud LG, Dawson-Hughes B, Shepherd JA, Wright NC (2012) Osteoporosis or low bone mass at the femur neck or lumbar spine in older adults: United States, 2005-2008. NCHS Data Brief:1–8 Looker AC, Borrud LG, Dawson-Hughes B, Shepherd JA, Wright NC (2012) Osteoporosis or low bone mass at the femur neck or lumbar spine in older adults: United States, 2005-2008. NCHS Data Brief:1–8
Metadata
Title
Determinants of imminent fracture risk in postmenopausal women with osteoporosis
Authors
R. L. Barron
G. Oster
A. Grauer
D. B. Crittenden
D. Weycker
Publication date
01-11-2020
Publisher
Springer London
Published in
Osteoporosis International / Issue 11/2020
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-020-05294-3

Other articles of this Issue 11/2020

Osteoporosis International 11/2020 Go to the issue